Mefenamic acid

From WikiMD's WELLNESSPEDIA

(Redirected from Mefenamic Acid)

2D structure of Mefenamic Acid

Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, including menstrual pain, and is sometimes used to treat arthritis. It is part of the anthranilic acid derivatives class of NSAIDs, also known as fenamates.

Chemical Structure and Properties[edit]

Mefenamic acid is chemically known as 2-[(2,3-dimethylphenyl)amino]benzoic acid. It is a white crystalline powder with a melting point of approximately 230°C. The molecular formula is C15H15NO2, and it has a molecular weight of 241.29 g/mol.

File:Mefenamic-acid-from-xtal-3D-bs-17.png
3D structure of Mefenamic Acid

The structure of mefenamic acid consists of a benzoic acid moiety linked to an aniline group, which is substituted with two methyl groups. This structure is responsible for its pharmacological activity as an NSAID.

Mechanism of Action[edit]

Mefenamic acid works by inhibiting the cyclooxygenase (COX) enzymes, COX-1 and COX-2, which are involved in the synthesis of prostaglandins. Prostaglandins are lipid compounds that play a key role in inflammation and pain. By reducing the production of prostaglandins, mefenamic acid alleviates pain and reduces inflammation.

Pharmacokinetics[edit]

After oral administration, mefenamic acid is absorbed from the gastrointestinal tract. It is extensively bound to plasma proteins, primarily albumin. The drug is metabolized in the liver to form several metabolites, which are then excreted in the urine.

File:Mefenamic acid metabolites.svg
Metabolites of Mefenamic Acid

The half-life of mefenamic acid is approximately 2 to 4 hours, and it is usually administered every 6 hours to maintain effective plasma concentrations.

Clinical Uses[edit]

Mefenamic acid is primarily used for the treatment of:

Side Effects[edit]

Common side effects of mefenamic acid include:

Serious side effects may include gastrointestinal bleeding, ulceration, and renal impairment.

Contraindications[edit]

Mefenamic acid should not be used in individuals with:

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.